Tier 1 — must know Canine Hematology Critical care

Immune-mediated hemolytic anemia

Regenerative hemolytic anemia · transfusion + immunosuppression + thromboembolism thinking · high-yield boards topic

⏱ 2–3 min read · Topic 6 of 6

5
Practice Qs
4
Traps
High
Exam freq.
Your status
Study mode
Quick anchor
Trigger
Regenerative anemia + spherocytes / agglutination
First step
Stabilize oxygen delivery; transfuse if needed
Treat
Immunosuppression + thrombosis awareness
Trap
Do not confuse with blood loss anemia
Exam core — read this first
Classic pattern → regenerative anemia, spherocytes, autoagglutination, icterus
If unstable → support oxygen delivery and transfuse as needed
Core therapy → immunosuppression, usually prednisone-based
Do not forget → thromboembolism risk is part of the disease
Clinical mechanism — only what matters
Immune destruction of RBCs → extravascular hemolysis is common
Severe anemia → poor oxygen delivery, tachycardia, weakness, collapse
Inflammatory / hypercoagulable state → thromboembolism risk matters

Boards focus on recognizing hemolysis and stabilizing a dangerous anemia, not memorizing every secondary cause list.

Pattern recognition
Core pattern
Pale or icteric dogRegenerative anemiaSpherocytes / agglutination
Supporting clues
TachycardiaPigmenturia possibleHyperbilirubinemiaWeakness / collapseFever possible
NAVLE trigger: If the anemia is regenerative and hemolytic, think IMHA before defaulting to hemorrhage.
Decision core — what NAVLE actually asks
Critically anemic patient
→ Stabilize oxygen delivery and transfuse while you continue the workup
Smear supports immune-mediated hemolysis
→ Start immunosuppressive therapy after appropriate sampling
Ongoing management
→ Monitor response and remember thrombosis prevention thinking
Key interpretation
PCV / HCT
↓ Low
Often severe
Reticulocytes
↑ Regenerative
Unless very early
Smear
Spherocytes
High-yield clue
Agglutination
Positive
Supports immune-mediated process
Bilirubin
↑ High
Common with hemolysis
Platelets
Check carefully
Evan's syndrome question may appear
⚠ A positive saline agglutination test and spherocytes are more board-useful than waiting for a Coombs result in the crashing patient.
Treatment
Stabilize
Packed RBC transfusion if oxygen delivery is inadequate
Do not let perfection delay rescue of the severely anemic patient.
Core Rx
Prednisone-based immunosuppression
Often the first board answer unless the question clearly asks about refractory disease.
Also
Think thromboprophylaxis and search for secondary triggers
The exam increasingly expects you to respect thromboembolism risk.
NAVLE traps — where students lose marks
Do not confuse hemolysis with simple blood loss
Spherocytes, icterus, and agglutination point you toward hemolysis.
Do not wait too long to transfuse the crashing dog
Stabilization matters before academic completeness.
Coombs is not the only way to support diagnosis
Boards often want smear plus saline agglutination reasoning.
Thrombosis risk is part of the disease
IMHA is not just an anemia question.
Differentials — how to separate these on NAVLE
Fast separator: IMHA is regenerative, hemolytic anemia. The board contrasts it with blood loss, toxin-mediated hemolysis, and infectious causes.
DiseaseRegenerative?Hemolysis cluesKey separator
IMHAUsually yesSpherocytes / agglutinationIcterus and immune-mediated pattern
Acute blood lossYes after delayNoExternal / internal hemorrhage clues
Zinc or oxidative hemolysisYesHemolysis yesHistory / Heinz body pattern
Babesia / infectious hemolysisYesHemolysis yesTravel / tick / organism clues
Nonregenerative anemiaNoNoMarrow or chronic disease logic
Mini cases — apply the decision framework
Recognition
A dog is weak, tachycardic, mildly icteric, and has regenerative anemia with spherocytes on smear. What diagnosis should move to the top?
Stabilization
The PCV is critically low and the dog is collapsing. What management principle comes first?
Trap reminder
Why is IMHA more than just “an anemia problem” on NAVLE?
Clinical application tools

These tools help with stabilization math and dose planning around a critically anemic patient.

30-second revision
Classic patternRegenerative anemia + spherocytes / agglutination
Physical cluesPale, weak, tachycardic, maybe icteric
StabilizeTransfuse if oxygen delivery is poor
Core therapyPrednisone-based immunosuppression
Useful evidenceSpherocytes + saline agglutination
Think broaderSearch for secondary trigger
Critical trapRemember thrombosis risk
Practice questions
Pre-built NAVLE-style · Immune-mediated hemolytic anemia
0 / 0
Q1Recognition
A dog has weakness, tachycardia, icterus, regenerative anemia, and marked spherocytosis on blood smear. Which diagnosis is most likely?
AAcute blood loss
BIron deficiency anemia
CImmune-mediated hemolytic anemia
DAnemia of chronic disease
EPrimary thrombocytopenia
Q2Stabilization
A dog with suspected IMHA is collapsing with a critically low PCV. What is the best immediate management principle?
ASupport oxygen delivery and transfuse as needed
BWait for Coombs testing before any therapy
CGive insulin first
DWithhold therapy until bilirubin normalizes
ESend the dog home on oral iron
Q3Evidence
Which finding most strongly supports immune-mediated hemolysis over simple blood loss anemia?
ARegeneration alone
BSpherocytes and positive saline agglutination
CLow hematocrit
DTachycardia
EWeak pulses
Q4Treatment
Which therapy is most central to initial treatment of primary canine IMHA?
ALevothyroxine
BDOCP
CInsulin CRI
DPrednisone-based immunosuppression
EDesmopressin
Q5Trap question
Why is canine IMHA considered especially high-risk even after initial stabilization?
ABecause it always converts to leukemia
BBecause it always causes DKA
CBecause thromboembolism risk is part of the disease
DBecause platelets are always zero
EBecause transfusion is contraindicated
Related topics